Cosmax Obtains Patent for New Microbial Culture Extract
[Asia Economy Reporter Park Jihwan] Cosmax announced on the 22nd that it has acquired a patent for the extract of the Starphylococcus simulans ST-9 strain culture fluid and its related skin condition improvement.
The company explained, "The strain according to the invention can improve skin aging by increasing the expression of collagen genes reduced by ultraviolet rays."
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
It also emphasized, "It can be usefully applied for the prevention, improvement, treatment of skin-related conditions or inflammation-related conditions, and strengthening of the skin barrier."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
